Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

113 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
No significant effect of SLCO1B1 polymorphism on the pharmacokinetics of rosiglitazone and pioglitazone.
Kalliokoski A, Neuvonen M, Neuvonen PJ, Niemi M. Kalliokoski A, et al. Among authors: neuvonen pj, neuvonen m. Br J Clin Pharmacol. 2008 Jan;65(1):78-86. doi: 10.1111/j.1365-2125.2007.02986.x. Epub 2007 Jul 17. Br J Clin Pharmacol. 2008. PMID: 17635496 Free PMC article. Clinical Trial.
Rifampin decreases the plasma concentrations and effects of repaglinide.
Niemi M, Backman JT, Neuvonen M, Neuvonen PJ, Kivistö KT. Niemi M, et al. Among authors: neuvonen pj, neuvonen m. Clin Pharmacol Ther. 2000 Nov;68(5):495-500. doi: 10.1067/mcp.2000.111183. Clin Pharmacol Ther. 2000. PMID: 11103752 Clinical Trial.
Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations.
Kyrklund C, Backman JT, Kivistö KT, Neuvonen M, Laitila J, Neuvonen PJ. Kyrklund C, et al. Among authors: neuvonen pj, neuvonen m. Clin Pharmacol Ther. 2000 Dec;68(6):592-7. doi: 10.1067/mcp.2000.111414. Clin Pharmacol Ther. 2000. PMID: 11180018 Clinical Trial.
Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride.
Niemi M, Backman JT, Neuvonen M, Laitila J, Neuvonen PJ, Kivistö KT. Niemi M, et al. Among authors: neuvonen pj, neuvonen m. Clin Pharmacol Ther. 2001 Apr;69(4):194-200. doi: 10.1067/mcp.2001.114229. Clin Pharmacol Ther. 2001. PMID: 11309547 Clinical Trial.
Plasma concentrations of active lovastatin acid are markedly increased by gemfibrozil but not by bezafibrate.
Kyrklund C, Backman JT, Kivistö KT, Neuvonen M, Laitila J, Neuvonen PJ. Kyrklund C, et al. Among authors: neuvonen pj, neuvonen m. Clin Pharmacol Ther. 2001 May;69(5):340-5. doi: 10.1067/mcp.2001.115542. Clin Pharmacol Ther. 2001. PMID: 11372002 Clinical Trial.
Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide.
Niemi M, Backman JT, Neuvonen M, Neuvonen PJ, Kivistö KT. Niemi M, et al. Among authors: neuvonen pj, neuvonen m. Clin Pharmacol Ther. 2001 Jun;69(6):400-6. doi: 10.1067/mcp.2001.115822. Clin Pharmacol Ther. 2001. PMID: 11406737 Clinical Trial.
Plasma concentrations of inhaled budesonide and its effects on plasma cortisol are increased by the cytochrome P4503A4 inhibitor itraconazole.
Raaska K, Niemi M, Neuvonen M, Neuvonen PJ, Kivistö KT. Raaska K, et al. Among authors: neuvonen pj, neuvonen m. Clin Pharmacol Ther. 2002 Oct;72(4):362-9. doi: 10.1067/mcp.2002.127397. Clin Pharmacol Ther. 2002. PMID: 12386638 Clinical Trial.
Gemfibrozil greatly increases plasma concentrations of cerivastatin.
Backman JT, Kyrklund C, Neuvonen M, Neuvonen PJ. Backman JT, et al. Among authors: neuvonen pj, neuvonen m. Clin Pharmacol Ther. 2002 Dec;72(6):685-91. doi: 10.1067/mcp.2002.128469. Clin Pharmacol Ther. 2002. PMID: 12496749 Clinical Trial.
Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and repaglinide.
Niemi M, Backman JT, Neuvonen M, Neuvonen PJ. Niemi M, et al. Among authors: neuvonen pj, neuvonen m. Diabetologia. 2003 Mar;46(3):347-51. doi: 10.1007/s00125-003-1034-7. Epub 2003 Feb 27. Diabetologia. 2003. PMID: 12687332 Clinical Trial.
Gemfibrozil increases plasma pravastatin concentrations and reduces pravastatin renal clearance.
Kyrklund C, Backman JT, Neuvonen M, Neuvonen PJ. Kyrklund C, et al. Among authors: neuvonen pj, neuvonen m. Clin Pharmacol Ther. 2003 Jun;73(6):538-44. doi: 10.1016/S0009-9236(03)00052-3. Clin Pharmacol Ther. 2003. PMID: 12811363 Clinical Trial.
113 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback